▁ins ul in , ▁instead ▁" ir on ically   ... ▁s elling ▁ins ul in ▁products ▁made ▁by ▁Nov o ▁Nord isk ▁Group ▁of ▁Den mark ." ▁ ▁Since ▁the ▁ 1 9 7 2 ▁sale ▁of ▁the ▁labor ator ies ▁to ▁the ▁CD C ▁st ip ulated ▁that ▁the ▁drug ▁firm ▁could ▁not ▁be ▁sold ▁to ▁a ▁foreign - owned ▁company , ▁University ▁of ▁Toronto ▁opposed ▁the ▁mer ger ▁" on ▁the ▁ground ▁that ▁a ▁foreign ▁take over ▁would ▁mean ▁a ▁loss ▁of ▁research ▁sp ending ▁and ▁jobs ▁in ▁Canada ." ▁It ▁took ▁Con n aught ▁to ▁court ▁seeking ▁an ▁inj unction ▁to ▁block ▁the ▁sale , ▁but ▁with d rew ▁its ▁ob jection ▁following ▁an ▁agreement ▁with ▁M érie ux ▁that ▁medical ▁research ▁support ▁will ▁continue ▁if ▁the ▁company ' s ▁bid ▁succeed s . ▁The ▁Canadian ▁government ▁approved ▁the ▁bid ▁for ▁Con n aught ▁in ▁December ▁ 1 9 8 9 . ▁The ▁move ▁was ▁critic ized ▁by ▁many , ▁including ▁Jim ▁Pet erson , ▁who ▁was ▁critical ▁of ▁Brian ▁Mul r oney ' s ▁industrial ▁policy ▁and ▁vo iced ▁that ▁" no ▁other ▁industrial ized ▁country   ... ▁would ▁permit ▁the ▁take over ▁of ▁its ▁leading ▁bi ote chn ology ▁firm ." ▁ ▁Con n aught ▁was ▁sold ▁to ▁M érie ux , ▁and ▁transformed ▁into ▁the ▁North ▁American ▁component ▁of ▁P aste ur ▁M érie ux ▁Con n aught ▁( P MC ) ▁owned ▁by ▁M érie ux ' s ▁parent ▁company , ▁Rh ône - P